Simultaneous liver and kidney transplantation

Current Opinion in Nephrology and Hypertension

Volumn 16, Issue 6, 2007, Pages 547-553

  Dube, Geoffrey K ^a   Cohen, David J ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

Kidney liver transplantation; Liver kidney transplantation; MELD score; Model for End Stage Liver Disease score; Renal failure

Indexed keywords

CREATININE BLOOD LEVEL; GRAFT SURVIVAL; HUMAN; INCIDENCE; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; MODEL FOR END STAGE LIVER DISEASE; ORGAN TRANSPLANTATION; PREOPERATIVE EVALUATION; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; SIMULTANEOUS LIVER AND KIDNEY TRANSPLANTATION; TREATMENT OUTCOME;

HUMANS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MULTIPLE ORGAN FAILURE; PATIENT SELECTION; TISSUE DONORS; TREATMENT OUTCOME;

EID: 37349123885     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e3282f1191e     Document Type: Review

References (38)

1. Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349:931-940.
2. Brown RS Jr, Lombardero M, Lake JR. Outcome of patients with renal insufficiency undergoing liver or liver-kidney transplantation. Transplantation 1996; 62:1788-1793.
3. Nair S, Verma S, Thuluvath PJ. Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 2002; 35:1179-1185.
4. Gonwa TA. Combined kidney liver transplant in the MELD era: where are we going? Liver Transpl 2005; 11:1022-1025.
5. Davis CL, Feng S, Sung R, et al. Simultaneous liver-kidney transplantation: evaluation to decision making. Am J Transplant 2007; 7:1702-1709. This is a very important review of a national consensus conference on the issues surrounding CLKT. It sets the agenda for the analysis of current practice and future investigation.
6. Davis CL, Gonwa TA, Wilkinson AH. Identification of patients best suited for combined liver-kidney transplantation: part II. Liver Transpl 2002; 8:193-211.
7. Salerno F, Gerbes A, Gines P, et al. Diagnosis, prevention and treatment of the hepatorenal syndrome in cirrhosis: a consensus workshop of the international ascites club. Gut 2007; 56:1310-1318. This paper reports the findings of an international workshop on the diagnosis of hepatorenal syndrome, highlighting innovative treatments.
8. Marik PE, Wood K, Starzl TE. The course of type 1 hepato-renal syndrome post liver transplantation. Nephrol Dial Transplant 2006; 21:478-482. This is a single-center review of the renal outcomes of patients with hepatorenal syndrome who received liver transplant alone.
9. Axelsen RA, Crawford DH, Endre ZH, et al. Renal glomerular lesions in unselected patients with cirrhosis undergoing orthotopic liver transplantation. Pathology 1995; 27:237-246.
10. Crawford DH, Endre ZH, Axelsen RA, et al. Universal occurrence of glomerular abnormalities in patients receiving liver transplants. Am J Kidney Dis 1992; 19:339-344.
11. McGuire BM, Julian BA, Bynon JS Jr, et al. Brief communication: glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation. Ann Intern Med 2006; 144:735-741.
12. Davis CL. Impact of pretransplant renal failure: when is listing for kidney-liver indicated? Liver Transpl 2005; 11:S35-S44.
13. Pichler RH, Dittrich MO, Anderson AE, et al. Prediction of benefit from simultaneous liver-kidney transplantation (SLK) versus liver-alone transplantation (LAT): potential role for native kidney biopsy. J Am Soc Nephrol 2006; 17:795A.
14. Sherman DS, Fish DN, Teitelbaum I. Assessing renal function in cirrhotic patients: problems and pitfalls. Am J Kidney Dis 2003; 41:269-278.
15. Cholongitas E, Marelli L, Kerry A, et al. Different methods of creatinine measurement significantly affect MELD scores. Liver Transpl 2007; 13:523-529.
16. Caregaro L, Menon F, Angeli P, et al. Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis. Arch Intern Med 1994; 154:201-205.
17. Cholongitas E, Marelli L, Kerry A, et al. Female liver transplant recipients with the same GFR as male recipients have lower MELD scores: a systematic bias. Am J Transplant 2007; 7:685-692. This paper examines the effects of gender-based differences in creatinine production on the MELD score. It suggests that the MELD formula may need to be adjusted to ensure equitable allocation of organs.
18. Orlando R, Mussap M, Plebani M, et al. Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis. Clin Chem 2002; 48:850-858.
19. Gonwa TA, Jennings L, Mai ML, et al. Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations. Liver Transpl 2004; 10:301-309.
20. Proulx NL, Akbari A, Garg AX, et al. Measured creatinine clearance from timed urine collections substantially overestimates glomerular filtration rate in patients with liver cirrhosis: a systematic review and individual patient meta-analysis. Nephrol Dial Transplant 2005; 20:1617-1622.
21. Skluzacek PA, Szewc RG, Nolan CR III, et al. Prediction of GFR in liver transplant candidates. Am J Kidney Dis 2003; 42:1169-1176.
22. MacAulay J, Thompson K, Kiberd BA, et al. Serum creatinine in patients with advanced liver disease is of limited value for identification of moderate renal dysfunction: are the equations for estimating renal function better? Can J Gastroenterol 2006; 20:521-526.
23. Poge U, Gerhardt T, Stoffel-Wagner B, et al. Calculation of glomerular filtration rate based on cystatin C in cirrhotic patients. Nephrol Dial Transplant 2006; 21:660-664. This paper examines the relationship between creatinine- and cystatin C-based GFR prediction equations and GFR as calculated by radionuclide studies. It highlights the difficulty in assessing renal function in liver transplant candidates.
24. Jouet P, Meyrier A, Mal F, et al. Transjugular renal biopsy in the treatment of patients with cirrhosis and renal abnormalities. Hepatology 1996; 24:1143-1147.
25. Sam R, Leehey DJ, Picken MM, et al. Transjugular renal biopsy in patients with liver disease. Am J Kidney Dis 2001; 37:1144-1151.
26. Campbell MS, Kotlyar DS, Brensinger CM, et al. Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation. Liver Transpl 2005; 11:1048-1055.
27. Ruiz R, Kunitake H, Wilkinson AH, et al. Long-term analysis of combined liver and kidney transplantation at a single center. Arch Surg 2006; 141:735-741. This is an excellent single-center study examining the relationship of hepatorenal syndrome requiring RRT to outcomes following LTA and CLKT.
28. Wong LP, Blackley MP, Andreoni KA, et al. Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy. Kidney Int 2005; 68:362-370.
29. Gonwa TA, McBride MA, Anderson K, et al. Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us? Am J Transplant 2006; 6:2651-2659. This is an important and thorough analysis of the outcomes of current practices in liver and liver-kidney transplantation as a function of renal insufficiency.
30. Baker TB, Snyder JA, Ahya S, Abecassis MA. Liver transplantation in the MELD era: to kidney or not? [abstract]. Am J Transplant 2007; 7 (Suppl 2):269.
31. Bozorgzadeh A, Orloff M, Abt P, et al. Dialysis postliver transplantation is associated with significantly decreased patient survival [abstract]. Am J Transplant 2007; 7 (Suppl 2):269.
32. Machicao VI, Srinivas TR, Hemming AW, et al. Impact of implementation of the MELD scoring system on the prevalence and incidence of chronic renal disease following liver transplantation. Liver Transpl 2006; 12:754-761. This is an interesting study examining short-term use of the MELD system on the development of CKD following liver transplantation.
33. Davis CL. Impact of implementation of the MELD scoring system on the prevalence and incidence of chronic renal disease following liver transplantation. Liver Transpl 2006; 12:707-709. This is an insightful editorial.
34. Katznelson S, Cecka JM. The liver neither protects the kidney from rejection nor improves kidney graft survival after combined liver and kidney transplantation from the same donor. Transplantation 1996; 61:1403-1405.
35. Fong TL, Bunnapradist S, Jordan SC, et al. Analysis of the United Network for Organ Sharing database comparing renal allografts and patient survival in combined liver-kidney transplantation with the contralateral allografts in kidney alone or kidney-pancreas transplantation. Transplantation 2003; 76: 348-353.
36. Creput C, Durrbach A, Samuel D, et al. Incidence of renal and liver rejection and patient survival rate following combined liver and kidney transplantation. Am J Transplant 2003; 3:348-356.
37. Simpson N, Cho YW, Cicciarelli JC, et al. Comparison of renal allograft outcomes in combined liver-kidney transplantation versus subsequent kidney transplantation in liver transplant recipients: analysis of UNOS Database. Transplantation 2006; 82:1298-1303. Thi article features an analysis of renal outcomes of CLKT and kidney after liver transplantation. It reviews the potential mechanisms by which CLKT may confer protection to the renal allograft from immunologic injury.
38. Gonwa TA, Mai ML, Melton LB, et al. End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment. Transplantation 2001; 72:1934-1939.